Business Description
Pulse Biosciences Inc
NAICS : 339113
SIC : 3841
ISIN : US74587B1017
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.92 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | -0.21 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 25.1 | |||||
3-Year EPS without NRI Growth Rate | 25.6 | |||||
3-Year FCF Growth Rate | 23.5 | |||||
3-Year Book Growth Rate | -3.5 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.37 | |||||
9-Day RSI | 45.25 | |||||
14-Day RSI | 45.06 | |||||
6-1 Month Momentum % | 30.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.06 | |||||
Quick Ratio | 7.06 | |||||
Cash Ratio | 6.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.2 | |||||
Shareholder Yield % | 12.49 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -116.49 | |||||
ROA % | -66.64 | |||||
ROIC % | -252.41 | |||||
ROC (Joel Greenblatt) % | -490.44 | |||||
ROCE % | -77.1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 11.05 | |||||
Price-to-Tangible-Book | 11.79 | |||||
EV-to-EBIT | -9.12 | |||||
EV-to-EBITDA | -9.37 | |||||
EV-to-Forward-Revenue | 7.94 | |||||
EV-to-FCF | -10.32 | |||||
Price-to-Net-Current-Asset-Value | 16.1 | |||||
Price-to-Net-Cash | 16.92 | |||||
Earnings Yield (Greenblatt) % | -10.97 | |||||
FCF Yield % | -8.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pulse Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.749 | ||
Beta | 2.7 | ||
Volatility % | 135.54 | ||
14-Day RSI | 45.06 | ||
14-Day ATR (€) | 0.265746 | ||
20-Day SMA (€) | 6.7125 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 3.54 - 11.4 | ||
Shares Outstanding (Mil) | 55.23 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pulse Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pulse Biosciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Pulse Biosciences Inc Frequently Asked Questions
What is Pulse Biosciences Inc(FRA:6L8)'s stock price today?
When is next earnings date of Pulse Biosciences Inc(FRA:6L8)?
Does Pulse Biosciences Inc(FRA:6L8) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |